3

SEC Filing Details

Document Details

Form
Filing Date
Mar 27, 2018
Document Date
Mar 21, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Nabriva Therapeutics
Issuer
Nabriva Therapeutics AG
Filer
Schranz Jennifer